Clinical Trials Browser

Interventional × HBI-8000 × Plasma cell × Clear all

NCT03605056 2018-07-30

Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM

Phase 2 Unknown

Multiple Myeloma